These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
FORM
|
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
|
|
(Exact name of Registrant as specified in its charter)
|
|
|
|
|
|
(State of other jurisdiction of incorporation or organization)
|
(I.R.S. Employer Identification No.)
|
|
|
|
|
|
|
(Address of principle executive offices)
|
(Zip Code)
|
|
(
|
|
(Registrant’s telephone number, including area code)
|
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
|
|
|
OTC Pink®
|
|
Large accelerated filer ☐
|
Accelerated filer ☐
|
||
|
|
Smaller reporting company
|
Emerging growth company
|
|
Class
|
Outstanding at July 31, 2022
|
|
|
Common Stock, $0.01 par value
|
|
|
PART I.
|
FINANCIAL INFORMATION
|
Page
|
|
Item 1.
|
Unaudited Condensed Consolidated Financial Statements
|
|
|
3
|
||
|
4
|
||
|
5
|
||
|
6
|
||
|
7
|
||
|
Item 2.
|
14
|
|
|
Item 3.
|
18
|
|
|
Item 4.
|
19
|
|
|
PART II.
|
OTHER INFORMATION *
|
|
|
Item 1.
|
19
|
|
|
Item 1A.
|
19
|
|
|
Item 6.
|
19 | |
|
20
|
|
June 30,
2022
|
December 31,
2021
|
|||||||
|
ASSETS
|
||||||||
|
Cash and cash equivalents
|
$
|
|
$
|
|
||||
|
Receivables from brokers and clearing organizations
|
|
|
||||||
|
Receivables from affiliates
|
|
|
||||||
|
Deposits with clearing organizations
|
|
|
||||||
|
Income taxes receivable (including deferred tax asset of $
|
|
|
||||||
|
Fixed assets, net of accumulated depreciation of $
|
|
|
||||||
|
Other assets
|
|
|
||||||
|
Total assets
|
$
|
|
$
|
|
||||
|
LIABILITIES AND EQUITY
|
||||||||
|
Compensation payable
|
$
|
|
$
|
|
||||
|
Payable to affiliates
|
|
|
||||||
|
Income tax payable
|
|
|
||||||
|
Accrued expenses and other liabilities
|
|
|
||||||
|
Total liabilities
|
|
|
||||||
|
Commitments and contingencies (Note J)
|
|
|
||||||
|
Equity
|
||||||||
|
Common stock, $
|
|
|
||||||
|
Additional paid-in capital
|
|
|
||||||
|
Accumulated deficit
|
(
|
)
|
(
|
)
|
||||
|
Total equity
|
|
|
||||||
|
Total liabilities and equity
|
$
|
|
$
|
|
||||
|
Three Months Ended June 30,
|
Six Months Ended June 30,
|
|||||||||||||||
|
2022
|
2021
|
2022
|
2021
|
|||||||||||||
|
Revenues
|
||||||||||||||||
|
Commissions
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
Principal transactions
|
|
(
|
)
|
|
(
|
)
|
||||||||||
|
Dividends and interest
|
|
|
|
|
||||||||||||
|
Underwriting fees
|
|
|
|
|
||||||||||||
|
Other revenues
|
|
|
|
|
||||||||||||
|
Total revenues
|
|
|
|
|
||||||||||||
|
Expenses
|
||||||||||||||||
|
Compensation and related costs
|
|
|
|
|
||||||||||||
|
Clearing charges
|
|
|
|
|
||||||||||||
|
General and administrative
|
|
|
|
|
||||||||||||
|
Occupancy and equipment
|
|
|
|
|
||||||||||||
|
Total expenses
|
|
|
|
|
||||||||||||
|
Loss before income tax benefit
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||||
|
Income tax benefit
|
|
|
|
|
||||||||||||
|
Net loss
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
||||
|
Net loss per share
|
||||||||||||||||
|
Basic and diluted
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
||||
|
Weighted average shares outstanding:
|
||||||||||||||||
|
Basic and diluted
|
|
|
|
|
||||||||||||
|
Shares
|
Common
Stock
|
Additional
Paid-in
Capital
|
Accumulated
Deficit
|
Total
|
||||||||||||||||
| Balance at December 31, 2020 | $ |
$ |
$ |
( |
) | $ |
||||||||||||||
| Net loss | - | ( |
) | ( |
) | |||||||||||||||
|
Balance at March 31, 2021
|
( |
) | ||||||||||||||||||
| Net loss | - |
( |
) | ( |
) | |||||||||||||||
|
Balance at June 30, 2021
|
( |
) | ||||||||||||||||||
|
Shares
|
Common
Stock
|
Additional
Paid-in
Capital
|
Accumulated
Deficit
|
Total
|
||||||||||||||||
|
Balance at December 31, 2021
|
$ | $ | $ | ( |
) | $ | ||||||||||||||
| Net loss | - | ( |
) | ( |
) | |||||||||||||||
|
Balance at March 31, 2022
|
( |
) | ||||||||||||||||||
| Net loss | - |
( |
) | ( |
) | |||||||||||||||
|
Balance at June 30, 2022
|
|
|
|
(
|
)
|
|
||||||||||||||
|
|
Six
months ended June 30,
|
|||||||
|
|
2022
|
2021
|
||||||
|
Cash flows from operating activities:
|
||||||||
|
Net loss
|
$
|
(
|
)
|
$
|
(
|
)
|
||
|
Adjustments to reconcile net loss to net cash used in operating activities:
|
||||||||
|
Depreciation
|
|
|
||||||
|
(Increase)/decrease in assets:
|
||||||||
|
Receivables from brokers and clearing organizations
|
(
|
)
|
(
|
)
|
||||
|
Receivables from affiliates
|
|
(
|
)
|
|||||
|
Income taxes receivable
|
(
|
)
|
|
|||||
|
Other assets
|
|
(
|
)
|
|||||
|
Increase/(decrease) in liabilities:
|
||||||||
|
Compensation payable
|
(
|
)
|
(
|
)
|
||||
|
Payable to affiliates
|
|
(
|
)
|
|||||
|
Income taxes payable
|
(
|
)
|
|
|||||
|
Accrued expenses and other liabilities
|
|
|
||||||
|
Total adjustments
|
|
(
|
)
|
|||||
|
Net cash used in operating activities
|
(
|
)
|
(
|
)
|
||||
|
|
||||||||
|
Net decrease in cash, cash equivalents, and restricted cash
|
(
|
)
|
(
|
)
|
||||
|
Cash, cash equivalents, and restricted cash at beginning of period
|
|
|
||||||
|
Cash, cash equivalents, and restricted cash at end of period
|
$
|
|
$
|
|
||||
|
|
||||||||
|
Reconciliation to cash, cash equivalents, and restricted cash:
|
||||||||
|
Cash and cash equivalents
|
$
|
|
$
|
|
||||
|
Restricted cash: deposits with clearing organizations
|
|
|
||||||
|
Cash, cash equivalents, and restricted cash
|
$
|
|
$
|
|
||||
|
Three months ended June 30,
|
Six months ended June 30,
|
|||||||||||||||
|
2022
|
2021
|
2022
|
2021
|
|||||||||||||
|
Commissions
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
Hard dollar payments
|
|
|
|
|
||||||||||||
|
|
|
|
|
|||||||||||||
|
Underwriting fees
|
|
|
|
|
||||||||||||
|
$
|
|
$
|
|
$
|
|
$
|
|
|||||||||
| - |
Level
1 inputs utilize quoted prices (unadjusted) in active markets for identical assets or liabilities. Level 1 assets include cash equivalents.
|
| - |
Level
2 inputs utilize inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly or indirectly. Level 2 inputs include quoted prices for similar assets and liabilities in active
markets and inputs other than quoted prices that are observable for the asset or liability, such as interest rates and yield curves that are observable at commonly quoted intervals.
|
| - |
Level
3 inputs are unobservable inputs for the asset or liability, and include situations where there is little, if any, market activity for the asset or liability. These assets include infrequently traded common stocks.
|
|
Assets
|
Quoted Prices in Active
Markets for Identical
Assets (Level 1)
|
Significant Other
Observable
Inputs (Level 2)
|
Significant
Unobservable
Inputs (Level 3)
|
Total
|
||||||||||||
|
Cash equivalents
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
Total assets at fair value
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
Assets
|
Quoted Prices in Active
Markets for Identical
Assets (Level 1)
|
Significant Other
Observable
Inputs (Level 2)
|
Significant
Unobservable
Inputs (Level 3)
|
Total
|
||||||||||||
|
Cash equivalents
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
Total assets at fair value
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
Three
Months Ended June 30,
|
Six Months Ended June 30,
|
|||||||||||||||
|
2022
|
2021
|
2022
|
2021
|
|||||||||||||
|
Basic and diluted:
|
||||||||||||||||
|
Net loss attributable
to shareholders
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
||||
|
Weighted average
shares outstanding
|
|
|
|
|
||||||||||||
|
Basic and diluted net
loss per share
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
||||
|
ITEM 2:
|
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
|
|
Three Months Ended June 30,
|
Six Months Ended June 30,
|
|||||||||||||||
|
2022
|
2021
|
2022
|
2021
|
|||||||||||||
|
Revenues
|
||||||||||||||||
|
Commissions
|
$
|
450
|
$
|
566
|
$
|
953
|
$
|
1,222
|
||||||||
|
Principal transactions
|
7
|
(2
|
)
|
7
|
(5
|
)
|
||||||||||
|
Dividends and interest
|
9
|
3
|
14
|
12
|
||||||||||||
|
Underwriting fees
|
-
|
-
|
-
|
6
|
||||||||||||
|
Other revenues
|
9
|
17
|
9
|
27
|
||||||||||||
|
Total revenues
|
475
|
584
|
984
|
1,263
|
||||||||||||
|
Expenses
|
||||||||||||||||
|
Compensation and related costs
|
293
|
627
|
621
|
1,315
|
||||||||||||
|
Clearing charges
|
228
|
164
|
458
|
350
|
||||||||||||
|
General and administrative
|
237
|
430
|
462
|
718
|
||||||||||||
|
Occupancy and equipment
|
68
|
85
|
141
|
163
|
||||||||||||
|
Total expenses
|
827
|
1,305
|
1,682
|
2,546
|
||||||||||||
|
Loss before income tax benefit
|
(351
|
)
|
(721
|
)
|
(698
|
)
|
(1,283
|
)
|
||||||||
|
Income tax benefit
|
-
|
-
|
-
|
-
|
||||||||||||
|
Net loss
|
$
|
(351
|
)
|
$
|
(721
|
)
|
$
|
(698
|
)
|
$
|
(1,283
|
)
|
||||
|
Net loss per share
|
||||||||||||||||
|
Basic and diluted
|
$
|
(0.59
|
)
|
$
|
(1.20
|
)
|
$
|
(1.16
|
)
|
$
|
(2.14
|
)
|
||||
|
Three Months Ended June 30,
|
Increase (Decrease)
|
|||||||||||||||
|
2022
|
2021
|
$ |
|
%
|
||||||||||||
|
Commissions
|
$
|
421
|
$
|
493
|
$
|
(72
|
)
|
-14.7
|
%
|
|||||||
|
Hard dollar payments
|
29
|
74
|
(44
|
)
|
-60.4
|
%
|
||||||||||
|
450
|
566
|
$
|
(117
|
)
|
-20.6
|
%
|
||||||||||
|
Underwriting fees
|
-
|
-
|
-
|
n/a
|
||||||||||||
|
Total
|
$
|
450
|
$
|
566
|
$
|
(117
|
)
|
-20.6
|
%
|
|||||||
|
Six Months Ended June 30,
|
Increase (Decrease)
|
|||||||||||||||
|
2022
|
2021
|
$ |
|
%
|
||||||||||||
|
Commissions
|
$
|
881
|
$
|
1,084
|
$
|
(204
|
)
|
-18.8
|
%
|
|||||||
|
Hard dollar payments
|
73
|
138
|
(65
|
)
|
-47.1
|
%
|
||||||||||
|
953
|
1,222
|
$
|
(269
|
)
|
-22.0
|
%
|
||||||||||
|
Underwriting fees
|
-
|
6
|
(6
|
)
|
-100.0
|
%
|
||||||||||
|
Total
|
$
|
953
|
$
|
1,228
|
$
|
(275
|
)
|
-22.4
|
%
|
|||||||
|
Six months ended June 30,
|
||||||||
|
2021
|
2020
|
|||||||
|
Cash flows provided by (used in) activities:
|
||||||||
|
Operating activities
|
$
|
(389
|
)
|
$
|
(1,460
|
)
|
||
|
Financing activities
|
-
|
-
|
||||||
|
Net decrease in cash and cash equivalents
|
(389
|
)
|
(1,460
|
)
|
||||
|
Cash and cash equivalents, beginning of period
|
2,889
|
4,746
|
||||||
|
Cash and cash equivalents, end of period
|
$
|
2,500
|
$
|
3,287
|
||||
| ITEM 3. |
QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
|
| ITEM 4. |
CONTROLS AND PROCEDURES
|
| PART II: |
OTHER INFORMATION
|
| ITEM 1. |
LEGAL PROCEEDINGS
|
| ITEM 1A. |
RISK FACTORS
|
| ITEM 6. |
EXHIBITS
|
| 31.1 | Certification of CEO pursuant to Rule 13a-14(a). |
| 31.2 | Certification of CAO pursuant to Rule 13a-14(a). |
| 32.1 | Certification of CEO pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. |
| 32.2 | Certification of CAO pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes- Oxley Act of 2002. |
| 101.INS |
XBRL Instance Document
|
| 101.SCH |
XBRL Taxonomy Extension Schema Document
|
| 101.CAL |
XBRL Taxonomy Extension Calculation Linkbase Document
|
| 101.DEF |
XBRL Taxonomy Extension Definition Linkbase Document
|
| 101.LAB |
XBRL Taxonomy Extension Label Linkbase Document
|
| 101.PRE |
XBRL Taxonomy Extension Presentation Linkbase Document
|
|
MORGAN GROUP HOLDING CO.
|
|
(Registrant)
|
|
By: /s/ Joseph L. Fernandez
|
|
Name: Joseph L. Fernandez
|
|
Title: Executive Vice President - Finance
|
|
Date: August 15, 2022
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|